| WASPIP |
IPI00552369 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
19.250 |
Evidence |
|
| WASPIP |
IPI00552369 |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
19.250 |
Evidence |
|
| WASPIP |
IPI00552369 |
GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
19.250 |
Evidence |
|
| COPE |
COPE: Coatomer subunit epsilon |
SGTA |
SGTA, SGT: Small glutamine-rich tetratricopeptide repeat-containing protein A |
19.250 |
Evidence |
|
| SNAP29 |
SNAP29: Synaptosomal-associated protein 29 |
VAMP2 |
VAMP2, SYB2: Vesicle-associated membrane protein 2 |
19.230 |
Evidence |
|
| GNG7 |
GNG7, GNGT7: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 p |
GNB2 |
GNB2: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 |
19.230 |
Evidence |
|
| GNB5 |
IPI00151607 |
GNG7 |
GNG7, GNGT7: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 p |
19.230 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
19.190 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
19.190 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
19.180 |
Evidence |
|
| NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
CAV1 |
CAV1, CAV: Caveolin-1 |
19.180 |
Evidence |
|
| EPB41 |
EPB41, E41P: Protein 4.1 |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
19.180 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
19.180 |
Evidence |
O
|
| NRAS |
HRAS, HRAS1: GTPase HRas precursor |
RASGRP3 |
RASGRP3, GRP3, KIAA0846: RAS guanyl-releasing protein 3 |
19.180 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
19.180 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
19.180 |
Evidence |
|
| CD74 |
IPI00217775 |
HLA-DRA |
|
19.160 |
Evidence |
|
| OXT |
OXT, OT: Oxytocin-neurophysin 1 precursor |
AVP |
IPI00000158 |
19.160 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
19.150 |
Evidence |
|
| EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
19.140 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
19.140 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
19.140 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
19.140 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
19.140 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
19.140 |
Evidence |
|